Nachrichten zur Madrigal Pharmaceuticals Corp. Aktie

Latest Ratings for MDGL DateFirmActionFromTo Oct 2021JefferiesInitiates Coverage OnBuy Aug 2021HC Wainwright & Co.MaintainsBuy May 2021Canaccord GenuityMaintainsBuy …

Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) announced positive topline results from the pivotal Phase 3 MAESTRO-NASH biopsy trial of resmetirom. Madrigal Pharmaceuticals…

Madrigals (MDGL) phase III MAESTRO-NASH study evaluating resmetirom for treating nonalcoholic steatohepatitis and liver fibrosis meets both primary endpoints. Stock…

Optimize Advisors' Mike Khouw looks at the action in Madrigal Pharmaceuticals on Friday ahead of a big clinical trial. With…

Kulmbach (www.aktiencheck.de) - Madrigal Pharmaceuticals-Aktienanalyse von "Der Aktionär": Martin Mrowka vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Madrigal…

Immer wieder sorgen positive Studienergebnisse von Pharma-Unternehmen für extreme Kurssprünge. Am Montag konnte Madrigal Pharmaceuticals sehr positive Neuigkeiten zu einem…

Health Care Slips, But Outpaces Market as Madrigal Rallies -- Health Care Roundup...…

Stocks that traded heavily or had substantial price changes Monday: Meta, L3Harris fall; Madrigal Pharmaceuticals rise...…

A late-stage trial of its drug resmetirom showed a 'best-case dataset' in resolving NASH and improving liver fibrosis....…

Madrigal Pharma Shares Hit 52-Week High After Positive Resmetirom Liver Treatment Trial...…

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

The company reported stellar late-stage clinical trial results for its experimental NASH (nonalcoholic steatohepatitis) drug....…

NEW YORK, Dec. 19, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MDGL, AMZN, MRNA, AAPL, and BIDU. Click…

Shares of Viking Therapeutics Inc. jumped 55% in premarket trading on Monday after a company that is also developing…

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Madrigal Pharmaceuticals Shares Triple After Positive Resmetirom Data...…

Shares of Madrigal Pharmaceuticals Inc. soared 209.6% in premarket trading on Monday after the company shared positive data from…

...(Reuters) - Madrigal Pharmaceuticals said on Monday its......…

...(Adds background) Dec 19 (Reuters) - Madrigal Pharmaceuticals said......…

CONSHOHOCKEN, Pa., Dec. 18, 2022 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company pursuing…

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Costa Rica’s economy would have an expected growth of 4.3 percent by the end of this year, according to the…